Generation of mature T cells from human hematopoietic stem and progenitor cells in artificial thymic organoids.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28369043.
- Also identified by DOI 10.1038/nmeth.4237 and PMC identifier 5426913.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Studies of human T cell development require robust model systems that recapitulate the full span of thymopoiesis, from hematopoietic stem and progenitor cells (HSPCs) through to mature T cells. Existing in vitro models induce T cell commitment from human HSPCs; however, differentiation into mature CD3<sup>+</sup>TCR-αβ<sup>+</sup> single-positive CD8<sup>+</sup> or CD4<sup>+</sup> cells is limited. We describe here a serum-free, artificial thymic organoid (ATO) system that supports efficient and reproducible in vitro differentiation and positive selection of conventional human T cells from all sources of HSPCs. ATO-derived T cells exhibited mature naive phenotypes, a diverse T cell receptor (TCR) repertoire and TCR-dependent function. ATOs initiated with TCR-engineered HSPCs produced T cells with antigen-specific cytotoxicity and near-complete lack of endogenous TCR Vβ expression, consistent with allelic exclusion of Vβ-encoding loci. ATOs provide a robust tool for studying human T cell differentiation and for the future development of stem-cell-based engineered T cell therapies.
Medical subject headings
- Artificial Organs
- Cell Differentiation
- Hematopoietic Stem Cells
- Organoids
- T-Lymphocytes
- Thymus Gland